MedTrace Logo

Evaluating a Patient-Centered Tool to Help Medicare Beneficiaries Choose Prescription Drug Plans

NCT02895295 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1185

Last updated 2019-07-23

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine whether providing Medicare beneficiaries with a web-based patient-centered decision tool to help them choose among prescription medication coverage plans improves outcomes for patients including a greater likelihood of changing a plan, better coverage for prescribed drugs, less decisional conflict when choosing plans, and greater satisfaction with the choice process relative to current practice.

Conditions

  • Prescription Drug Insurance Decision Making

Interventions

BEHAVIORAL

Expert Recommendation

Decision support tool that provides personalized information on the financial implications of enrolling in different plans and expert recommendations of particular plans.

BEHAVIORAL

Individual Analysis

Decision support tool that provides personalized information on the financial implications of enrolling in different plans.

BEHAVIORAL

Usual Care

Study subjects randomized to the control arm will receive information on how to download their prescription drug information from their electronic medical record and provided with a list of resources available in the community to help them choose a prescription drug plan.

Sponsors & Collaborators

  • Palo Alto Medical Foundation

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • Stanford University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
66 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-10
Primary Completion
2017-01-20
Completion
2017-01-20

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02895295 on ClinicalTrials.gov